Olema Pharmaceuticals Inc (OLMA)
EBITDA Growth
-44.55%
Quarterly · Period ending:
OLMA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-44.55%period ending
Latest reported-44.55%period ending
OLMA Quarterly EBITDA YoY % (-898.72% → -44.55%)
Year-over-year change
High-resolution chart · PNG
OLMA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -44.5478% | |
| -75.0438% | |
| -37.1379% | |
| -22.3854% | |
| -44.1231% | |
| 2.0109% | |
| -25.3598% | |
| -60.9378% | |
| -51.4703% | |
| -9.565% | |
| -2.3081% | |
| 5.3781% | |
| 38.9864% | |
| -22.8362% | |
| -20.946% | |
| -28.1153% | |
| -100.1405% | |
| -48.6044% | |
| -112.9456% | |
| -125.2359% | |
| -568.0947% | |
| -1,389.0068% | |
| -898.7179% |